secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001213900-22-069538
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avra Medical Robotics to acquire CardioVentures in reverse merger; SSI-DE holders to get 95% of stock
--------------------------------------------------------------------------------

- SSI-DE stockholders to receive 95% of post-merger Avra common stock plus Series A Preferred shares with 51% voting power.
- Avra provided $1.44M interim financing to SSI-DE; up to $5M in convertible notes sold to three accredited investors.
- Conditions include 1-for-10 reverse stock split, name change to 'SS Innovations, Inc.', and authorized shares increase to 250M.
- Dr. Srivastava to assign SSI intellectual property to Avra; current Avra directors to resign except Barry Cohen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/0001213900-22-069538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/ea168119-8k_avramedical.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-069538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer